Becton Dickinson plans to invest more than $30M in 2025 to expand its manufacturing capacity for IV lines at its Utah plant.

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...

Becton, Dickinson, headquartered in Franklin Lakes, New Jersey, said it plans to invest more than $30 million in 2025 to increase manufacturing of IV lines and boost output of catheter solutions.

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...

Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including ...

Wealth Enhancement Advisory Services LLC increased its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free ...

Here is how Alvotech (ALVO) and Becton Dickinson (BDX) have performed compared to their sector so far this year.

Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. With a market cap ...